Tirzepatide (GLP-1 + GIP) - Dual Metabolic Reset Weight Loss Program
Tirzepatide (GLP-1 + GIP) - Dual Metabolic Reset Weight Loss Program
Compounded tirzepatide is a dual GLP-1 and GIP receptor agonist. It acts on receptors involved in appetite regulation and glucose-dependent insulin secretion. A licensed healthcare provider will determine whether compounded tirzepatide is clinically appropriate for an individual patient. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
- GLP-1 + GIP Tirzepatide Weight Loss Program
- Reduces cravings and hunger
- Microdose or Weekly injection protocols
Weight Loss Without Extreme Diets
Reach your goal weight without crash diets
Shed Stubborn Fat & Maintain Results
Promote a balanced metabolism that helps you feel more energized and keep the weight off for good.
Control Cravings & Feel Fuller Longer
Curb hunger and stay satisfied between meals, so eating less feels effortless.
Boost Energy Levels Through The Roof
Enjoy elevated energy levels that keep you active, focused, and motivated all day.
Vitali-T vs The Competition
Expert Strategies for Lasting Change
Weight Gain
Tiredness
Sluggishness
Poor Sleep
Sweet Cravings
Low Energy
Body Aches
Weakness
FAQ
How does Tirzepatide work?
How does Tirzepatide work?
Dual agonist that activates GLP-1 and GIP receptors to reduce appetite, slow digestion, improve blood sugar control, and support weight loss.
How is it taken?
How is it taken?
Tirzepatide is given as a subcutaneous injection once weekly but this can be individualized, with the dose gradually increased based on response and tolerability.
What are the main side effects?
What are the main side effects?
The most common side effects include nausea, diarrhea, constipation, vomiting, indigestion, and abdominal discomfort, particularly when starting treatment or increasing the dose.
When is it available?
When is it available?
Tirzepatide is currently available by prescription for eligible patients.